← Back to news

Markets

Tesla Earnings: What Robotaxi Updates Should Investors Expect?

Y

Here’s How Cedar Grove Capital Management Benefitted from Its Short Position in Hims & Hers Health (HIMS)

Y

I'm 62 with $1.2 million in investments, but I don’t own my home. Can I afford to leave my husband?

Y

Truist Adjusts Community Health Systems, Inc. (CYH) Outlook Within Broader Sector Update

Y

Logistics layoffs top 800 as contracts unwind across trucking, warehousing

Y

T-Mobile assumed with an Overweight at Morgan Stanley

Y

Wall Street indexes rally after Iran says Strait of Hormuz 'completely open'

Y

SAP price target lowered to $250 from $300 at TD Cowen

Y

Gold Heads For Fourth Weekly Gain

Y

M&T Bank price target raised to $235 from $233 at DA Davidson

Y

Are You Actually Getting No Tax on Social Security When You File Taxes This Year?

Y

Morgan Stanley Just Named Affirm Its Top Pick: Private Credit Fears Are Overdone and a May Catalyst Could Be Huge

Y

Should You Invest in F&G Annuities & Life (FG)?

Y

Sompo teams up with Zego as it joins $28m fundraising

Y

Kevin O'Leary got choked up sharing 4 investing rules his mom followed for 55 years to put two kids through college

Y

Multimedia retailer QVC Group begins Chapter 11 process

Y

RBC Flags Seasonal Pressures Impacting Karyopharm Therapeutics Inc. (KPTI) Short-Term Performance

Y

Evercore Maintains Positive Stance on MeiraGTx Holdings plc (MGTX) Amid Sector Revisions

Y

Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline Refocus

Y

Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability

Y

Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value

Y

Northland Highlights ARS Pharmaceuticals, Inc. (SPRY) Needle-Free Therapy as Major Innovation Driver

Y

Jefferies Sees Reduced Visibility for Replimune Group, Inc. (REPL) Following FDA Decision

Y

Evercore Adjusts Fortrea Holdings Inc. (FTRE) Valuation Following Updated Near-Term Assumptions

Y

Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile

Y

B. Riley Sees Upside in MacroGenics, Inc. (MGNX) Following Gilead-Driven Sector Activity

Y

Oil prices fall as US-Iran talks and ceasefire spur hopes

Y

Gold Gains 1.5% As U.S.-Iran Diplomacy Hopes Grow

Y

Lassonde ends drinks packaging operations at Canadian facility

Y

Better Crypto Buy Right Now: Ethereum vs. Solana

Y

Australia’s BIG W cuts prices on 2,000 items amid cost pressures

Y

Better Bond ETF: Schwab's SCHQ vs. State Street's SPLB

Y

Liberty Mutual quietly added a stranger to a man’s car insurance, which more than doubled his premiums. He had no idea

Y

Morgan Stanley Adjusts Gilead Sciences, Inc. (GILD) Outlook Ahead of Q1 Earnings

Y

Middle Coast Investing is Watching Gitlab’s (GTLB) Growth Story

Y

Truist Sees Continued Upside for The Pennant Group, Inc. (PNTG) on Stable Demand Trends

Y

BTIG Adjusts Merit Medical Systems, Inc. (MMSI) Model Ahead of Medicare Payment Changes

Y

Mizuho Adjusts Haemonetics Corporation (HAE) Estimates in Sector-Wide Review

Y

Leerink Sees Limited Near-Term Upside for Zimmer Biomet Holdings, Inc. (ZBH) Ahead of 2027 Catalysts

Y

Here’s Middle Coast Investing’s Views on Booking Holdings (BKNG)

Y

Do You Think Capital One Financial (COF) is a Sensitive Company?

Y

Stock Market Today: Dow Rallies On Hormuz Reopening; Lithium Name Sinks (Live Coverage)

Y

Intuitive Surgical, Inc. (ISRG) Price Target Lowered at BITG Amid CMS FY27 Payment Rule Impact

Y

Boston Scientific Corporation (BSX) Price Target Lowered at Mizuho Ahead of Q1 Medical Device Earnings

Y

What Makes Standard Aero (SARO) an Exciting Position in Middle Coast Investing’s Portfolio?

Y

Health Canada Imposes New Conditions on Grifols, S.A. (GRFS) Plasma Collection Centers

Y

Eli Lilly and Company (LLY) Price Target Increased At Morgan Stanley on Updated Biopharma Model Assumptions

Y

KeyBanc Turn Bullish on T-Mobile US, Inc. (TMUS) Ahead of Potential Earnings Catalyst

Y

The Simply Good Foods Company (SMPL) Flags Declining Distribution and Retail Trends for SMPL

Y

Baird Sees Reduced Catalyst Potential for CoStar Group, Inc. (CSGP) After Third Point Exit

Y